Alliance Pharma PLC Exercise of Share Options (3770G)
March 03 2015 - 3:30AM
UK Regulatory
TIDMAPH
RNS Number : 3770G
Alliance Pharma PLC
03 March 2015
For immediate release 3 March 2015
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Exercise of Share Options
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical
company, announces that following the exercise of employee share
options on 2 March 2015, application has been made by Alliance for
a further 14,300 ordinary shares of 1 pence each in the Company
("Ordinary Shares") to be admitted to trading on AIM.
It is expected that these new Ordinary Shares, which will rank
pari passu in all respects with the existing Ordinary Shares, will
be admitted to trading on 6 March 2015.
Following the exercise of the options, Alliance will have
264,162,665 Ordinary Shares in issue.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
Buchanan + 44 (0) 20 7466 5000
Mark Court / Sophie Cowles / Jane
Glover
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade /
Freddie Barnfield
Corporate Broking: David Poutney
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has a strong track record of acquiring the rights to
established niche products and owns or licenses the rights to more
than 60 pharmaceutical products and continues to explore
opportunities to expand the range.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLIFFAVRIVIIE
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2024 to May 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From May 2023 to May 2024